Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Releases New Guidelines For Drug And Device Price Reforms

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's top economic planner, the National Development and Reform Commission together with the Ministry Of Health and the Ministry of Human Resources and Social Security released Nov. 23 a new guideline to further reform pricing measures for drugs and devices

You may also be interested in...



China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases

SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list

China Releases First Part Of Essential Drug List For Community Health Clinics And Rural Hospitals

SHANGHAI - China's Ministry Of Health released Aug. 18 the first part of the essential drug list for community health organizations, which consists of 205 chemical drugs and biologics as well as 102 traditional Chinese Medicines. The implementation will begin Sept. 21 in 30 percent of the government-run low-tier hospitals and clinics

Medical Device Sector Expected To Gain The Most From China’s Healthcare Reform

SHANGHAI- China's medical device market has reached RMB 83 billion ($12.1 billion), roughly one-eighth of the total healthcare industry, according to a report by Frost & Sullivan

Related Content

UsernamePublicRestriction

Register

SC070470

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel